CVM.V - CVR Medical Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.28
-0.01 (-3.45%)
At close: 3:57PM EDT
Stock chart is not supported by your current browser
Previous Close0.29
Open0.28
Bid0.28 x 0
Ask0.28 x 0
Day's Range0.27 - 0.28
52 Week Range0.24 - 0.50
Volume34,600
Avg. Volume86,148
Market Cap21.739M
Beta (3Y Monthly)1.98
PE Ratio (TTM)N/A
EPS (TTM)-0.11
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile17 days ago

    CVR Medical Shareholders Approve Restructure

    The Approved Restructuring Provides Clarity, Responsibility and Accountability While Paving the Way to Long-term Success Vancouver, British Columbia--(Newsfile Corp. - September 28, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that on September 26, 2018 the Board of Directors for CVR Medical Corp. (CVM) held a Special Meeting of the Shareholders to approve amongst many things the Restructuring of the Agreement between CVR Medical Corp. and CVR Global ...

  • Newsfile2 months ago

    CVR Medical Announces Proposed Financing

    Vancouver, British Columbia--(Newsfile Corp. - August 23, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces that it intends to complete a non-brokered private placement financing (the "Financing") of units (each, a "Unit") for gross proceeds of up to C$2,000,000 with a price per Unit of C$0.30 or such other price determined by CVR Medical management ...

  • CVR Medical Reports Positive Interim Results from Ongoing Pivotal Trial with CSS Device
    Newsfile2 months ago

    CVR Medical Reports Positive Interim Results from Ongoing Pivotal Trial with CSS Device

    Preliminary Analysis Demonstrates CSS Device Has To Date Exceeded Expectations for Specificity and Sensitivity Compared to Duplex Doppler Ultrasound Vancouver, British Columbia--(Newsfile Corp. - August 21, 2018) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces advisory staff member Dr. Phillip J. Bendick, PhD, has released an internal report summarizing data from the pivotal clinical trials for the Carotid Stenotic ...

  • CVR Medical Enlists JD Lymon Group to Provide Reimbursement and Study Design Support
    Newsfile2 months ago

    CVR Medical Enlists JD Lymon Group to Provide Reimbursement and Study Design Support

    Vancouver, British Columbia--(Newsfile Corp. - August 14, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), a Canadian listed and US based healthcare company in the medical device sector, has retained the services of Minneapolis-based medical device consulting firm, JD Lymon Group (www.jdlymon.com), to provide ongoing reimbursement guidance and to help support the company's FDA submission of the Carotid Stenotic Scan (CSS) device for US market clearance by ...

  • Newsfile2 months ago

    CVR Medical Retains Global IR/PR Firm ICR To Support Financing and Commercialization Efforts For Its Carotid Stenotic Scan (CSS)

    Vancouver, British Columbia--(Newsfile Corp. - August 9, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), a Canadian listed and US based healthcare company in the medical device sector, has retained the services of NYC based Investor Relations Public Relations Firm ICR (www.icrinc.com) to support the company's communications and marketing activities as it explores a US National Market listing and advances toward regulatory submission for its Carotid Stenotic Scan ...

  • CVR Medical Retains Investment Banking Firm ThinkEquity, A Division of Fordham Financial Management, Inc.
    Newsfile4 months ago

    CVR Medical Retains Investment Banking Firm ThinkEquity, A Division of Fordham Financial Management, Inc.

    Company To Explore US Capital Markets Up-Listing Vancouver, British Columbia--(Newsfile Corp. - June 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces it has exclusively retained ThinkEquity, a division of Fordham Financial Management, Inc., a NYC based, investment banking firm to explore listing onto a major exchange in the United States.CVR CSS DeviceTo view an enhanced version of this graphic, please visit:https://orders.newsfilecorp.com/files/1933/35088_cvr6june2018nr.jpgAbout CVR MedicalCVR Medical is a company involved ...

  • Newsfile5 months ago

    CVR Medical And CVR Global Reach Strategic Agreement

    Accord Lays Pathway for Long Term Success Vancouver, British Columbia--(Newsfile Corp. - May 29, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has reached agreement with joint venture partner CVR Global to acquire CVR Global's 50% interest in the joint venture and terminate the joint venture (the "Transaction"). The Agreement has been approved by the Board of Directors for both organizations and is now subject to the approval ...

  • Newsfile5 months ago

    CVR Medical Retains BUYINS.NET to Surveil Short Sellers and Market Makers

    Vancouver, British Columbia--(Newsfile Corp. - May 22, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces it has retained BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on CVR Medical (OTCQB: CRRVF) (TSXV: CVM) (FSE: B3BN) after releasing the latest short sale data through May 17, 2018. The total aggregate number of shares shorted ...

  • CVR Medical Adds Colonel Dallas Hack MD, MPH, MSS, FACMPH, FS, CPE To Board of Directors
    Newsfile5 months ago

    CVR Medical Adds Colonel Dallas Hack MD, MPH, MSS, FACMPH, FS, CPE To Board of Directors

    Vancouver, British Columbia--(Newsfile Corp. - May 10, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces Colonel Dallas C. Hack, MD, MPH, MSS, FACMPH, FS, CPE has been unanimously appointed to its Board of Directors, replacing Mr. Erwin Wong who is retiring. Colonel Hack is a brain injury expert and is board certified in Preventive Medicine with multiple degrees and certifications including a Master of Public Health and a ...

  • CVR & U.S. FDA: A Meeting of the Minds
    Newsfile5 months ago

    CVR & U.S. FDA: A Meeting of the Minds

    Concludes De Novo Pathway Best Suited Vancouver, British Columbia--(Newsfile Corp. - May 9, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the receipt of official meeting minutes for their Pre-Submission meeting on March 23, 2018 with the U.S. Food and Drug Administration (FDA) regarding the Carotid Stenotic Scan (CSS) device and it's upcoming FDA submission for market release. Attendees of the meeting included CVR management, regulatory consultant's Duval & ...

  • Canon Showcasing Carotid Stenotic Scan (CSS) at NPE the World's Leading Plastic Tradeshow
    Newsfile5 months ago

    Canon Showcasing Carotid Stenotic Scan (CSS) at NPE the World's Leading Plastic Tradeshow

    Vancouver, British Columbia--(Newsfile Corp. - May 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") is pleased to announce that Canon Virginia, Inc. (CVI) will be showcasing our Carotid Stenotic Scan (CSS) at NPE 2018: The Plastics Show, the world's leading plastic tradeshow. Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., provides custom manufacturing solutions, including mold making, injection molding, medical contract manufacturing and automated ...

  • Newsfile5 months ago

    CORRECTION: Tom J. Harris Former CFO at Time Warner Cable And Associated Press Appointed Chief Financial Officer Of CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - May 3, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Mr. Tom J. Harris to the position of Chief Financial Officer effective May 1, 2018. As CVR transitions to a sales and marketing focused company, Mr. Erwin Wong retires from his position as CFO. Tom J. Harris will spearhead fiscal preparations while contributing to overall organizational expansions as CVR continues ...

  • Newsfile5 months ago

    Tom J. Harris Former CFO at Time Warner Cable And Associated Press Appointed Chief Financial Officer Of CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - May 3, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Mr. Tom J. Harris to the position of Chief Financial Officer effective May 1, 2018. As CVR transitions to a sales and marketing focused company, Mr. Erwin Wong retires from his position as CFO. Tom J. Harris will spearhead fiscal preparations while contributing to overall organizational expansions as CVR continues ...

  • Newsfile5 months ago

    CVR Medical Bolsters Board Appoints Wayne Hellman Vice-Chairman

    Global Thought Leader and Entrepreneur Adds Tremendous Expertise in New Product Launches, International Expansion and Manufacturing Vancouver, British Columbia--(Newsfile Corp. - May 1, 2018) - CVR Medical Corp. (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the addition of Mr. Wayne Hellman to its Board of Directors and appointment as Vice Chairman. Mr. Hellman will assume an active role focused on the continued development and upcoming launch of CVR Medical's ...

  • Newsfile7 months ago

    CORRECTION: CVR Medical Announces Temporary Warrant Exercise Price Amendment

    Company To Host Conference Call CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018 at 5:30 a.m. PST) whereby access code to the conference call scheduled for March 19, 2018 at 1:00 p.m. EST (10:00 a.m. PST) is a 7-digit number only. The complete and corrected release follows.Vancouver, British Columbia--(Newsfile Corp. - March ...

  • Newsfile7 months ago

    CVR Medical Announces Temporary Warrant Exercise Price Amendment

    Company To Host Conference Call Vancouver, British Columbia--(Newsfile Corp. - March 16, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants originally issued in February and April 2017 (the "2017 Warrants") from CAD $0.70 (the "Original Exercise Price") to CAD $0.40 (the "Amended Exercise Price") for the period commencing on March 16, 2018 and ending ...

  • Newsfile7 months ago

    Second Trial Data Report: Clinical Substantiation for CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - March 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") advisory staff member Dr. Phillip J. Bendick, PhD, has completed his second clinical report summarizing additional data collected from tertiary clinical trials for the Carotid Stenotic Scan (CSS) device. His report confirms the evaluation stated in the prior report, issued in September 2017, which predicted improved accuracy in the ability to identify the narrowing of ...

  • Newsfile8 months ago

    CVR Medical Expands Clinical Footprint

    Vancouver, British Columbia--(Newsfile Corp. - February 27, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces Internal Review Board (IRB) approval by The Cleveland Clinic, sanctioning CVR to conduct clinical trials using the Carotid Stenotic Scan (CSS) device. The trial will be overseen by Primary Investigator Dr. Heather Gornik, Medical Director of the Non-Invasive Vascular Laboratory in the Cleveland Clinic Department of Cardiovascular Medicine.Cleveland Clinic was voted the number ...

  • Newsfile8 months ago

    Critical Milestone: CVR Medical to Launch Pivotal Trials

    Vancouver, British Columbia--(Newsfile Corp. - February 20, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the launch of pivotal clinical trials beginning Monday March 5, 2018 for the Carotid Stenotic Scan (CSS) device. This anticipated milestone represents the final phase of clinical substantiation which CVR will use to support the upcoming FDA submission. Initially, Thomas Jefferson University Hospital (Philadelphia, PA) and Henry Ford Hospital (Detroit, MI) ...

  • Newsfile8 months ago

    CVR Medical Adds Two Wireless CSS Devices to Methodist Hospital Expanding Clinical Substantiation Data for FDA Submission

    Vancouver, British Columbia--(Newsfile Corp. - February 13, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces placement of two additional wireless Carotid Stenotic Scan (CSS) devices into clinical trials at historic Methodist Hospital, part of the Thomas Jefferson University Hospital System. This deployment will be combined with the three wireless CSS devices already in use across the Thomas Jefferson University Hospital footprint. This critical milestone will assist ...

  • CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018
    Newsfile8 months ago

    CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018

    Vancouver, British Columbia--(Newsfile Corp. - February 8, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") has joined Canon Virginia, Inc. (CVI) at PLASTEC West (February 6 - 8, 2018), the largest domestic conference and expo for advanced design and manufacturing of plastics technologies. CVI, subsidiary of Canon U.S.A., Inc, is the sole manufacturer of the cart for CVR Medical's "Carotid Stenotic Scan (CSS)" device.CVI is sharing a ...

  • Newsfile8 months ago

    CVR Medical Moving Forward With Touch Panels From Hitachi High Technologies America

    Vancouver, British Columbia--(Newsfile Corp. - February 6, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") announces the placement of an initial order of touch panel PC's for its "Carotid Stenotic Scan (CSS)" device. This order represents the preliminary inventory build necessary for an FDA submission and subsequent market launch. Hitachi High Technologies America, Inc. ("HTA") designed the unique core processor for the CSS, which CVR believes ...

  • Newsfile8 months ago

    CVR Medical Entering Into Pre-Pivotal Trial Phase A Step Closer To FDA Clearance

    Vancouver, British Columbia--(Newsfile Corp. - February 1, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the launch of their Pre-Pivotal Trial clinical substantiation phase for the "Carotid Stenotic Scan (CSS)" device. This critical stage, prior to launch of final phase Pivotal Trials, will be conducted at Thomas Jefferson University Hospital (Philadelphia, PA), Henry Ford Hospital (Detroit, MI), and several other top-tier clinical research institutions within the United States. ...

  • Newsfile8 months ago

    CVR Medical Announces Proposed Financing

    Vancouver, British Columbia--(Newsfile Corp. - January 31, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that it intends to complete a private placement financing for gross proceeds of up to $2,000,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share and one-half of one common share purchase warrant at a price of $0.40 per unit, or such other price per unit determined ...

  • Newsfile9 months ago

    CVR Medical Corp.: Rapid Progress Toward FDA Submission - Clinical Trials Commence At Henry Ford Hospital

    Vancouver, British Columbia--(Newsfile Corp. - January 23, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the commencement of clinical data acquisition by the Carotid Stenotic Scan (CSS) device at the renowned Henry Ford Hospital. There is currently one wireless CSS device fully deployed within the Henry Ford system, with two additional devices slated for implementation in the subsequent weeks. This clinical trial plays a crucial role in accelerating clinical substantiation for the CSS device and ...